Literature DB >> 34731254

Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants.

Deepali Gupta1, Priyanka Sharma2, Mandeep Singh1, Mukesh Kumar1, A S Ethayathulla1, Punit Kaur3.   

Abstract

Since the emergence of the first case of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), the viral genome has constantly undergone rapid mutations for better adaptation in the host system. These newer mutations have given rise to several lineages/ variants of the virus that have resulted in high transmission and virulence rates compared to the previously circulating variants. Owing to this, the overall caseload and related mortality have tremendously increased globally to > 233 million infections and > 4.7 million deaths as of Sept. 28th, 2021. SARS-CoV-2, Spike (S) protein binds to host cells by recognizing human angiotensin-converting enzyme 2 (hACE2) receptor. The viral S protein contains S1 and S2 domains that constitute the binding and fusion machinery, respectively. Structural analysis of viral S protein reveals that the virus undergoes conformational flexibility and dynamicity to interact with the hACE2 receptor. The SARS-CoV-2 variants and mutations might be associated with affecting the conformational plasticity of S protein, potentially linked to its altered affinity, infectivity, and immunogenicity. This review focuses on the current circulating variants of SARS-CoV-2 and the structure-function analysis of key S protein mutations linked with increased affinity, higher infectivity, enhanced transmission rates, and immune escape against this infection.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Lineages; S protein; SARS-CoV-2; Structure-functional analysis; Variant of concern (VOC)

Mesh:

Substances:

Year:  2021        PMID: 34731254     DOI: 10.1007/s00018-021-04008-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  89 in total

1.  Fullerene nanoparticles for the treatment of ulcerative colitis.

Authors:  Xiaodan Liao; Zhongpu Zhao; Hui Li; Bo Wu; Jiawei Huo; Lei Li; Xue Li; Xinran Cao; Min Xia; Chunru Wang; Chunli Bai
Journal:  Sci China Life Sci       Date:  2021-11-02       Impact factor: 10.372

Review 2.  Structure, Function, and Evolution of Coronavirus Spike Proteins.

Authors:  Fang Li
Journal:  Annu Rev Virol       Date:  2016-08-25       Impact factor: 10.431

3.  Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling.

Authors:  Andrew R Jauregui; Dhruti Savalia; Virginia K Lowry; Cara M Farrell; Marc G Wathelet
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

4.  SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.

Authors:  Giovanni Salvatori; Laura Luberto; Mariano Maffei; Luigi Aurisicchio; Giuseppe Roscilli; Fabio Palombo; Emanuele Marra
Journal:  J Transl Med       Date:  2020-06-03       Impact factor: 5.531

Review 5.  Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.

Authors:  Rohitash Yadav; Jitendra Kumar Chaudhary; Neeraj Jain; Pankaj Kumar Chaudhary; Supriya Khanra; Puneet Dhamija; Ambika Sharma; Ashish Kumar; Shailendra Handu
Journal:  Cells       Date:  2021-04-06       Impact factor: 6.600

Review 6.  SARS coronavirus 2: from genome to infectome.

Authors:  Meghana Rastogi; Neha Pandey; Astha Shukla; Sunit K Singh
Journal:  Respir Res       Date:  2020-12-01

7.  Efficacy and Safety of HLX03, an Adalimumab Biosimilar, in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blind, Phase III Study.

Authors:  Lin Cai; Linfeng Li; Hao Cheng; Yangfeng Ding; Zhenshu Biao; Shifa Zhang; Songmei Geng; Quanzhong Liu; Hong Fang; Zhiqi Song; Yan Lu; Shanshan Li; Qing Guo; Juan Tao; Li He; Jun Gu; Qinping Yang; Xiuping Han; Xinghua Gao; Danqi Deng; Shenqiu Li; Qingyu Wang; Jun Zhu; Jianzhong Zhang
Journal:  Adv Ther       Date:  2021-11-23       Impact factor: 3.845

Review 8.  SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat.

Authors:  Jun Zheng
Journal:  Int J Biol Sci       Date:  2020-03-15       Impact factor: 6.580

9.  Selective pressure on SARS-CoV-2 protein coding genes and glycosylation site prediction.

Authors:  Alessandra Lo Presti; Giovanni Rezza; Paola Stefanelli
Journal:  Heliyon       Date:  2020-09-21

Review 10.  COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies.

Authors:  Renuka Raman; Krishna J Patel; Kishu Ranjan
Journal:  Biomolecules       Date:  2021-07-06
View more
  9 in total

Review 1.  Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.

Authors:  Cong Sun; Chu Xie; Guo-Long Bu; Lan-Yi Zhong; Mu-Sheng Zeng
Journal:  Signal Transduct Target Ther       Date:  2022-06-28

Review 2.  Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: Mutational impacts, concerns, and the possible solutions.

Authors:  Fahadul Islam; Manish Dhawan; Mohamed H Nafady; Talha Bin Emran; Saikat Mitra; Om Prakash Choudhary; Aklima Akter
Journal:  Ann Med Surg (Lond)       Date:  2022-05-07

Review 3.  Spike protein of SARS-CoV-2 variants: a brief review and practical implications.

Authors:  Kattlyn Laryssa Candido; Caio Ricardo Eich; Luciana Oliveira de Fariña; Marina Kimiko Kadowaki; José Luis da Conceição Silva; Alexandre Maller; Rita de Cássia Garcia Simão
Journal:  Braz J Microbiol       Date:  2022-04-09       Impact factor: 2.214

4.  Analysis of SARS-CoV-2 Variants From 24,181 Patients Exemplifies the Role of Globalization and Zoonosis in Pandemics.

Authors:  Philippe Colson; Pierre-Edouard Fournier; Hervé Chaudet; Jérémy Delerce; Audrey Giraud-Gatineau; Linda Houhamdi; Claudia Andrieu; Ludivine Brechard; Marielle Bedotto; Elsa Prudent; Céline Gazin; Mamadou Beye; Emilie Burel; Pierre Dudouet; Hervé Tissot-Dupont; Philippe Gautret; Jean-Christophe Lagier; Matthieu Million; Philippe Brouqui; Philippe Parola; Florence Fenollar; Michel Drancourt; Bernard La Scola; Anthony Levasseur; Didier Raoult
Journal:  Front Microbiol       Date:  2022-02-07       Impact factor: 5.640

5.  Inhibitors of Activin Receptor-like Kinase 5 Interfere with SARS-CoV-2 S-Protein Processing and Spike-Mediated Cell Fusion via Attenuation of Furin Expression.

Authors:  Maja C Mezger; Carina Conzelmann; Tatjana Weil; Pascal von Maltitz; Dan P J Albers; Jan Münch; Thomas Stamminger; Eva-Maria Schilling
Journal:  Viruses       Date:  2022-06-15       Impact factor: 5.818

Review 6.  Molecular dynamics studies reveal structural and functional features of the SARS-CoV-2 spike protein.

Authors:  Ludovico Pipitò; Roxana-Maria Rujan; Christopher A Reynolds; Giuseppe Deganutti
Journal:  Bioessays       Date:  2022-07-17       Impact factor: 4.653

Review 7.  T cells in SARS-CoV-2 infection and vaccination.

Authors:  Arthur Young
Journal:  Ther Adv Vaccines Immunother       Date:  2022-08-24

8.  Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern.

Authors:  Erika Rudi; Pablo Martin Aispuro; Eugenia Zurita; Maria M Gonzalez Lopez Ledesma; Daniela Bottero; Juan Malito; Magali Gabrielli; Emilia Gaillard; Matthew Stuible; Yves Durocher; Andrea V Gamarnik; Andrés Wigdorovitz; Daniela Hozbor
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

Review 9.  SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines.

Authors:  Suresh Thakur; Shalitha Sasi; Sindhu Gopinathan Pillai; Ayantika Nag; Dhananjay Shukla; Ritu Singhal; Sameer Phalke; G S K Velu
Journal:  Front Med (Lausanne)       Date:  2022-02-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.